about
CD8 T cell persistence in treated HIV infectionSimilarity in viral and host promoters couples viral reactivation with host cell migrationΔ(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesiclesCirculating Fibroblast Growth Factor-2, HIV-Tat, and Vascular Endothelial Cell Growth Factor-A in HIV-Infected Children with Renal Disease Activate Rho-A and Src in Cultured Renal Endothelial Cells.Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort studyPlatelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study.SIV/SHIV Infection Triggers Vascular Inflammation, Diminished Expression of Krüppel-like Factor 2 and Endothelial Dysfunction.Comparison of the therapeutic dose of warfarin in HIV-infected and HIV-uninfected patients: a study of clinical practice.Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy.Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice.Refining Current Scientific Priorities and Identifying New Scientific Gaps in HIV-Related Heart, Lung, Blood, and Sleep Research.Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy.Endogenous LINE-1 (Long Interspersed Nuclear Element-1) Reverse Transcriptase Activity in Platelets Controls Translational Events Through RNA-DNA Hybrids.Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection.Pathogenic factors associated with development of disseminated intravascular coagulopathy (DIC) in a tertiary academic hospital in South Africa.Trends in pulmonary embolism in patients infected with HIV during the combination antiretroviral therapy era in Spain: A nationwide population-based study
P2860
Q27014768-424E8B21-12F5-4AA8-9D65-2CBA12B0A60EQ33640033-44103DF4-0A10-48E2-8B14-A3F24D12D824Q35748304-B38823DC-187D-4761-B919-70DBB9AAFC6CQ35994961-AF95EA0A-0CA1-45EF-8253-57AC1E21A2EFQ36098224-C12A5074-536E-4306-A58F-FF950730C10BQ36244001-4C9851D4-9ABC-444A-AAC4-126458D646B4Q36745235-97DFBC55-1EC1-4065-A627-07E75C1AB4B3Q37639964-A434DA77-ECF6-4F48-9EA5-E76A947750A5Q38601647-CC49B5FA-037D-439A-9CA6-868BFB66C2DDQ38732518-5519AA14-7B45-4C7B-B958-4E17AC35E05FQ40191380-393FC208-A0FD-4FB5-84BA-6F1386F5100EQ40367422-4B94D48B-E4D6-4893-BC38-5262D3F903E2Q47231567-E22088B2-E754-41BA-A50B-5356947F4158Q51779710-50884234-0853-4839-8F11-713CE5BA1748Q53693401-A2EA4586-A588-4339-A36F-866E8015B7CFQ57276037-F7CCDA98-EC13-438D-A486-15D19A2F6DD4
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Coagulation and morbidity in treated HIV infection.
@ast
Coagulation and morbidity in treated HIV infection.
@en
type
label
Coagulation and morbidity in treated HIV infection.
@ast
Coagulation and morbidity in treated HIV infection.
@en
prefLabel
Coagulation and morbidity in treated HIV infection.
@ast
Coagulation and morbidity in treated HIV infection.
@en
P2860
P1433
P1476
Coagulation and morbidity in treated HIV infection.
@en
P2093
Michael M Lederman
P2860
P356
10.1016/J.THROMRES.2014.03.012
P478
133 Suppl 1
P577
2014-05-01T00:00:00Z